Ensure Trial Integrity with Effective Clinical Quality Oversight

 October 20–22, 2020   Virtual Event

Register Now! Group

Optimize Quality in A Remote Clinical World

Join us at #CQOF2020 as we discuss how to assure the quality, compliance, and data integrity without the ability to visit the site or see source documentation.

Now in our 11th year, and our first year as an exclusively virtual event, our Clinical Quality Oversight Forum is taking place October 20-22.  The global pandemic has added a new complication to this topic and forced many to quickly adopt and transition to processes that can be conducted remotely, so we’ll be featuring case studies on process transformation and discussing what’s working well and is here to stay.

Learn More Group

Benefits of Attending a Fierce Virtual Event

1

Expert Sessions

Ask questions, read speaker bios, chat; no one will shush you.

2

Break-out Discussions

Participate over video in deep dive discussions with your peers during mini breakout sessions.

3

Partner Content Hub

Binge watch multimedia content direct from the exhibitors.

4

Exhibit Hall

Meet exhibitors 1 on 1 over video to review case studies, explore offerings. Ask all the questions!

5

Always On

Power went out? Had to walk the dog? Watch it again anytime for up to 6 months.


"The conference and speakers were all excellent. This was a very valuable conference and input from the participants will improve our quality oversight of vendors.”
Auditor, Quality Assurance, INFINITY PHARMACEUTICALS

FEATURED SPEAKERS

Reinhard

Sharon S. Reinhard, M.S

Vice President, R&D QA,

CSL BEHRING

Celeste

Celeste Gonzalez, B.S., CVT, RQAP-GCP, CCRP

Principal Specialist, Clinical Quality Assurance,

BOSTON SCIENTIFIC

Cheryl

Cheryl McCarthy, CQA, CBA, RQAP- GCP

Director, Research Quality

IRONWOOD PHARMACEUTICALS

david

David Fryrear

Senior Vice President, Head of Clinical and Research Quality Assurance

ASTELLAS

jolie

Jolie Weintraub

Associate Vice President, Clinical Quality Assurance

MERCK

Audience demographics from our July 2020 virtual event on Optimizing Clinical Quality During A Pandemic

84% represent qualified participants from pharma, biotech and device companies 

Company Type

31

Biotech

17

Large Pharma

14

Mid-Sized Pharma

13

Small Pharma

9

Medical Device

7

Academic/ Government/ Non-Profit 

4

Consultant

2

CRO

2

Technology Solution Provider

1

Other 

Sponsoring Organizations